Literature DB >> 33624581

Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018.

Eun Jeong Won, Min Ji Choi, Mi-Na Kim, Dongeun Yong, Wee Gyo Lee, Young Uh, Taek Soo Kim, Seung Ah Byeon, Seung Yeob Lee, Soo Hyun Kim, Jong Hee Shin.   

Abstract

Entities:  

Keywords:  Candida glabrata; PDR1; South Korea; antimicrobial resistance; candidemia; fluconazole resistance; fungal infections; fungi; mortality

Mesh：

Substances：

Year:  2021        PMID： 33624581      PMCID： PMC7920659          DOI： 10.3201/eid2703.203482

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  47 in total

1.  MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Caroline Agnelli; Ana Gómez-Nuñez; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Changing epidemiology of non-albicans candidemia in Korea.

Authors:  Jae-Hoon Ko; Dong Sik Jung; Ji Yeon Lee; Hyun Ah Kim; Seong Yeol Ryu; Sook-In Jung; Eun-Jeong Joo; Shinhye Cheon; Yeon-Sook Kim; Shin-Woo Kim; Sun Young Cho; Cheol-In Kang; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck
Journal:  J Infect Chemother       Date:  2018-10-26       Impact factor: 2.211

3.  Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.

Authors:  Ingi Lee; Knashawn H Morales; Theoklis E Zaoutis; Neil O Fishman; Irving Nachamkin; Ebbing Lautenbach
Journal:  Am J Infect Control       Date:  2010-06-12       Impact factor: 2.918

4.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Authors:  David L Horn; Dionissios Neofytos; Elias J Anaissie; Jay A Fishman; William J Steinbach; Ali J Olyaei; Kieren A Marr; Michael A Pfaller; Chi-Hsing Chang; Karen M Webster
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

5.  Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multicenter Study in China.

Authors:  Xin Hou; Meng Xiao; He Wang; Shu-Ying Yu; Ge Zhang; Yanan Zhao; Ying-Chun Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

6.  Mortality in patients with early- or late-onset candidaemia.

Authors:  Francesco Giuseppe De Rosa; Enrico Maria Trecarichi; Chiara Montrucchio; Angela Raffaella Losito; Stefania Raviolo; Brunella Posteraro; Silvia Corcione; Simona Di Giambenedetto; Lucina Fossati; Maurizio Sanguinetti; Roberto Serra; Roberto Cauda; Giovanni Di Perri; Mario Tumbarello
Journal:  J Antimicrob Chemother       Date:  2012-12-12       Impact factor: 5.790

7.  Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage.

Authors:  Eun Jeong Won; Jong Hee Shin; Min Ji Choi; Wee Gyo Lee; Yeon-Joon Park; Young Uh; Shine-Young Kim; Mi-Kyung Lee; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

8.  Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts.

Authors:  Xin Hou; Meng Xiao; Sharon C-A Chen; He Wang; Shu-Ying Yu; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  Front Microbiol       Date:  2017-01-19       Impact factor: 5.640

9.  Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study.

Authors:  Xin Hou; Meng Xiao; Sharon C-A Chen; Fanrong Kong; He Wang; Yun-Zhuo Chu; Mei Kang; Zi-Yong Sun; Zhi-Dong Hu; Ruo-Yu Li; Juan Lu; Kang Liao; Tie-Shi Hu; Yu-Xing Ni; Gui-Ling Zou; Ge Zhang; Xin Fan; Yu-Pei Zhao; Ying-Chun Xu
Journal:  Front Microbiol       Date:  2017-05-23       Impact factor: 5.640

10.  Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes.

Authors:  Seung A Byun; Eun Jeong Won; Mi-Na Kim; Wee Gyo Lee; Kyungwon Lee; Hye Soo Lee; Young Uh; Kelley R Healey; David S Perlin; Min Ji Choi; Soo Hyun Kim; Jong Hee Shin
Journal:  Front Microbiol       Date:  2018-07-13       Impact factor: 5.640
View more
  2 in total

1.  Intrinsically High Resistance of Candida glabrata to Hydrogen Peroxide and Its Reversal in a Fluconazole-Resistant Mutant.

Authors:  Tom Edlind; Santosh Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2022-08-02       Impact factor: 5.938

2.  Comparative genomic analysis of clinical Candida glabrata isolates identifies multiple polymorphic loci that can improve existing multilocus sequence typing strategy.

Authors:  A Arastehfar; M Marcet-Houben; F Daneshnia; S J Taj-Aldeen; D Batra; S R Lockhart; E Shor; T Gabaldón; D S Perlin
Journal:  Stud Mycol       Date:  2021-11-29       Impact factor: 16.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.